V9HWB8 (V9HWB8_HUMAN) Homo sapiens (Human)

Pyruvate kinase UniProtKBInterProInteractive Modelling

531 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: P14618; Pan troglodytes: H2Q9R1, A0A6D2XQL7; Pan paniscus: A0A2R9C418; Gorilla gorilla gorilla: A0A2I2YRU7

Available Structures

55 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of M2 PYK in complex with Alanine.homo-4-mer5-531
PO4;ALA;
Assess
Crystal structure of human pyruvate kinase M2 isoformhomo-4-mer6-531
SER;PO4;
Assess
Activator-Bound Structure of Human Pyruvate Kinase M2homo-4-mer13-531
FBP;TLA;DYY; 18×UNX;ADP;
Assess
PKM2 bound to compound 2homo-4-mer13-531
YII; 12×EDO;OXL; 40×SO4;MG;NA;
Assess
Pyruvate Kinase M2 Mutant-K433Qhomo-4-mer13-531
14×GOL;OXL;MG;NO3;K;CL;
Assess
Activator-Bound Structure of Human Pyruvate Kinase M2homo-4-mer13-531
FBP; 21×UNX;07T;
Assess
Crystal Structure of PKM2 mutant C474Shomo-4-mer13-531
FBP;OXL;EDO;MG;GOL;
Assess
Pyruvate Kinase M2 mutant-N70Dhomo-4-mer13-531
OXL;MG; 11×GOL;FBP;
Assess
Crystal Structure of Human PKM2 in Complex with L-asparaginehomo-4-mer13-531
K; 17×GOL;OXL;FBP;MG;CL;ASN;144;
Assess
2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as Novel PKM2 Activatorshomo-4-mer13-531
FBP;1OX;
Assess
Crystal Structure of PKM2 mutant P403Ahomo-4-mer13-531
OXL;GOL;EDO;MG;FBP;
Assess
Crystal Structure of PKM2 mutant R516Chomo-4-mer13-531
FBP;OXL;EDO;GOL; 10×PO4;MG;
Assess
Human Pyruvate Kinase M2homo-4-mer13-531
FBP;OXL;PO4;MG;K; 20×GOL;
Assess
Human M2 pyruvate kinase in complex with fructose 1-6 bisphosphate and Oxalate.homo-4-mer13-531
OXL;FBP;K;MG;GOL;
Assess
Activator-Bound Structure of Human Pyruvate Kinase M2homo-4-mer14-531
FBP;TLA;UNX;DZG;
Assess
Activator-Bound Structure of Human Pyruvate Kinase M2homo-4-mer14-531
3SZ;FBP;SO4; 42×UNX;
Assess
S437Y Mutant of human muscle pyruvate kinase, isoform M2homo-4-mer14-531
13×SO4; 31×UNX;
Assess
Activator-Bound Structure of Human Pyruvate Kinase M2homo-4-mer14-531
FBP; 31×UNX;D8G;
Assess
Pyruvate kinase M2 is a phosphotyrosine binding proteinhomo-4-mer14-531
FBP;OXL;K;MG;
Assess
PKM2 in complex with compound 2homo-4-mer14-531
FBP;7XX;
Assess
Crystal Structure of Human PKM2 in Complex with L-cysteinehomo-4-mer14-531
CYS;FBP;MG;OXL;K;
Assess
human PKM2 with L-serine and FBP bound.homo-4-mer14-531
SER;FBP;MG;
Assess
PKM2 in complex with an activatorhomo-4-mer14-531
OXL;MG;NZT;
Assess
Crystal structure of PKM2 mutanthomo-4-mer14-531
PYR;MG;SER;FBP;
Assess
Pyruvate kinase M2 is a phosphotyrosine binding proteinhomo-4-mer14-531
OXL;MG;
Assess
Human M2 pyruvate kinasehomo-4-mer14-531
PO4;
Assess
Crystal structure of PKM2 R399E mutant complexed with FBP and serinehomo-4-mer14-531
FBP;SER;PYR;MG;K;
Assess
Human M1 pyruvate kinasehomo-4-mer14-531
PO4;K;MG;PYR;GOL;
Assess
Crystal Structure of Human PKM2 in Complex with L-aspartatehomo-4-mer14-531
K; 12×GOL;CL;FBP;MG;OXL;ASP;PEG;
Assess
Human Pyruvate Kinase M2 Mutant C424Ahomo-4-mer14-531
OXD;FBP;K;MG;GOL;PO4;SO4;
Assess
PKM2 in complex with compound 5homo-4-mer14-531
FBP;7Y0;
Assess
Crystal Structure of PKM2 mutant L144Phomo-4-mer15-531
OXL;FBP;MG;EDO;
Assess
Crystal Structure of Human PKM2 in Complex with L-valinehomo-4-mer15-531
CL;K;MG;FBP; 12×GOL;OXL;VAL;
Assess
PKM2 in complex with Compound 5homo-4-mer18-531
LZ2;FBP;
Assess
PKM2 in complex with Compound 6homo-4-mer19-531
NXE;FBP;DMS;
Assess
Pyruvate Kinase M2 mutant-S37Ehomo-4-mer21-531
11×PO4;MG;K;OXL; 18×GOL;CL;
Assess
Pyruvate Kinase M2 mutant-S37Dhomo-4-mer21-531
K;GOL;MG;OXL;FBP;
Assess
Crystal structure of M2 PYK in complex with Serine.homo-4-mer22-531
K;MG;SER;PO4;
Assess
PKM2 in complex with L-threoninehomo-4-mer22-531
FBP;THR;
Assess
PKM2 in complex with Compound 10homo-4-mer22-531
NXH;FBP;
Assess
Crystal structure of M2 PYK in complex with Phenyalanine.homo-4-mer23-531
PO4;PHE;K;
Assess
crystal structure of PKM2-K422R mutant bound with FBPhomo-4-mer23-531
FBP;
Assess
Structure of M2 pyruvate kinase in complex with phenylalaninehomo-4-mer23-531
PO4;PHE;
Assess
Crystal structure of M2 PYK in complex with Tryptophan.homo-4-mer23-531
PO4;TRP;K;
Assess
crystal structure of PKM2-K422R mutanthomo-4-mer24-531
K;SO4;GOL;
Assess
crystal structure of PKM2-K305Q mutanthomo-4-mer24-531
MG;K;GOL;MLI;
Assess
crystal structure of PKM2-R399E mutanthomo-4-mer24-531
MG;ACT;
Assess
Pyruvate Kinase M2 mutant-S37E K433Ehomo-4-mer24-531
NO3;MG;OXL;GOL;
Assess
Human PKM2 mutant - C326Shomo-4-mer24-531
Assess
crystal structure of PKM2-Y105E mutanthomo-4-mer24-531
PRO;
Assess
Structure of human muscle pyruvate kinase (PKM2)homo-4-mer25-531
Assess
Structure of M2 pyruvate kinase in complex with phenylalaninehomo-4-mer26-531
OXL;K;MG;FBP;ATP;
Assess
Pyruvate Kinase M2 mutant - S437Yhomo-2-mer7-531
MG;OXL;K;CL;SCN;PEG;B3P;PG4;EDO;
Assess
Pyruvate Kinase M2 Mutant - S437Y in Complex with L-cysteinehomo-2-mer7-531
CYS;OXL;SCN;B3P;MG;K;EDO;
Assess
Pyruvate Kinase M2 Mutant - S437Y in Complex with L-serinehomo-2-mer7-531
SER;MG;OXL;K;SCN;PEG;B3P;PG4;EDO;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8g2e.1.Dhomo-4-mer0.8813-531
YII;OXL;100.00
Assess